Successful treatment of macrophage activation syndrome complicating adult-onset Still’s disease with tocilizumab: a case report
Keyword(s):
Abstract We report a case of 50-year-old female patient with adult-onset Still’s disease (AOSD) complicated by macrophage-activation syndrome (MAS). After initial control of the disease with high-dose parenteral corticosteroids, tocilizumab (TCZ) therapy aided in maintaining the remission with rapid tapering of steroid dose. TCZ may be useful for MAS complicating AOSD.
2020 ◽
Vol 12
◽
pp. 1759720X2097485
2020 ◽
Vol 4
(2)
◽
pp. 202-207
◽
2016 ◽
Vol 26
(3)
◽
pp. 309-311
◽
2018 ◽
Vol 5
(1)
◽
pp. 27
2019 ◽
pp. annrheumdis-2019-216286
◽
2016 ◽
Vol 45
(6)
◽
pp. 711-716
◽
2019 ◽
Vol 40
(1)
◽
pp. 145-152
◽